Fluoropyrimidine-mediated radiosensitization depends on cyclin E-dependent kinase activation

Fluoropyrimidines radiosensitize human colon cancer cells that progress into S phase in the presence of drug (M.A. Davis, H-Y. Tang, J. Maybaum, and T.S. Lawrence. Int. J. Radiat. Biol. 67. 509-512, 1995). We hypothesized that progression occurs in cells that generate elevated levels of cyclin E-dep...

Full description

Saved in:

Bibliographic Details
Published in:	Cancer research (Chicago, Ill.) Vol. 56; no. 14; pp. 3203 - 3206
Main Authors:	LAWRENCE, T. S, DAVIS, M. A, LONEY, T. L
Format:	Journal Article
Language:	English
Published:	Philadelphia, PA American Association for Cancer Research 15-07-1996
Subjects:	Biological and medical sciences Cell Cycle - drug effects Cyclin D1 Cyclin-Dependent Kinases - metabolism Cyclins - metabolism DNA, Neoplasm - metabolism Enzyme Activation - drug effects Floxuridine - pharmacology Humans Medical sciences Oncogene Proteins - metabolism Radiation therapy and radiosensitizing agent Radiation-Sensitizing Agents - pharmacology Signal Transduction Treatment with physical agents Treatment. General aspects Tumor Cells, Cultured - cytology Tumors Human Enzyme Fluoropyrimidine derivatives Malignant tumor In vitro Mechanism Resistance Radiosensitization Enzymatic activity Kinase Established cell line Digestive diseases Intestinal disease Colon Tumor cell
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Fluoropyrimidines radiosensitize human colon cancer cells that progress into S phase in the presence of drug (M.A. Davis, H-Y. Tang, J. Maybaum, and T.S. Lawrence. Int. J. Radiat. Biol. 67. 509-512, 1995). We hypothesized that progression occurs in cells that generate elevated levels of cyclin E-dependent kinase activity despite the presence of the fluoropyrimidine. To test this hypothesis, we treated HT29 and SW620 human colon cancer cells with fluorodeoxyuridine under conditions that produced nearly complete inhibition of thymidylate synthase but which sensitized only the HT29 cells. We found that, whereas HT29 cells progressed into S phase and demonstrated increased cyclin E-dependent kinase activity, SW620 cells arrested just past the G1-S boundary and showed no change in kinase activity. Because these cell lines have the same p53 mutation, these findings suggest that there is a p53-independent G1-S checkpoint that mediates radiosensitization produced by fluorodeoxyuridine.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0008-5472 1538-7445